Regeneron Email Format

Biotechnology
10,001-25,000 employees
Tarrytown, NY, USA

Regeneron is a leading biotechnology company that invents, develops, and commercializes life-transforming medicines for people with serious diseases across a global network.

Find contacts at Regeneron

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

first.last@regeneron.com

Company Overview

Industry
Biotechnology
Founded
1988
Headquarters
Tarrytown, NY, USA
Revenue
$10B-$25B
FUNDING Stage
Public
Key Executives
Leonard S. Schleifer (Board co-Chair, President and Chief Executive Officer), Christopher Fenimore (Executive Vice President, Finance and Chief Financial Officer), Ryan Steinberger (Executive Vice President, Chief Digital & Technology Officer)

Tech Stack

Databricks

Analytics

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Regeneron?

Regeneron uses the first.last format on regeneron.com, so Jane Smith would be jane.smith@regeneron.com.

What are Regeneron's best-known approved medicines?

Regeneron's most recognized medicines include EYLEA (aflibercept) for wet age-related macular degeneration, Dupixent (dupilumab) for allergic and inflammatory diseases, and Libtayo (cemiplimab) for advanced skin and lung cancers. The company has 15 approved or authorized treatments developed in-house.

How does the Regeneron Genetics Center support Regeneron's drug discovery efforts?

The Regeneron Genetics Center uses large-scale human genetics and DNA sequencing to identify novel drug targets, validate research programs, and optimize clinical trials. It has sequenced hundreds of thousands of whole genomes to help drive new medicine discovery.

Which therapeutic areas does Regeneron focus on?

Regeneron researches and develops medicines across ophthalmology, allergic and inflammatory diseases, oncology and hematology, cardiovascular and metabolic diseases, neuroscience, and rare diseases, with clinical trials running in more than 50 countries worldwide.

Who leads Regeneron as its chief executive?

Leonard S. Schleifer serves as President and Chief Executive Officer of Regeneron and also holds the role of Board co-Chair. If you need to find a specific Regeneron contact or verify an email address, a tool like Clay can help you enrich and confirm that outreach data.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles